Area of research
Pharmacology · Cellular and Molecular Neuroscience
Research interest
Research focused on Cannabis and Ketamine, with related work in Psychosis, Schizophrenia (object-oriented programming), Functional magnetic resonance imaging. Notable publications include 'Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia', 'Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis', and 'Cannabis-associated psychosis: Neural substrate and clinical impact'.
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis
Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis
Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia
Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans
Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence
Test-retest reliability of time-frequency measures of auditory steady-state responses in patients with schizophrenia and healthy controls
Cannabis-associated psychosis: Neural substrate and clinical impact
Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment
Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia
Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia
The Psychosis-like Effects of Δ9-Tetrahydrocannabinol Are Associated With Increased Cortical Noise in Healthy Humans
Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ9-THC in Humans